Alyana A Samai1, Amelia K Boehme2, Amir Shaban3, Alexander J George3, Lauren Dowell3, Dominique J Monlezun3, Cindy Leissinger4, Laurie Schluter3, Ramy El Khoury3, Sheryl Martin-Schild5. 1. Stroke Program, Department of Neurology, Tulane University School of Medicine, New Orleans, Louisiana; Department of Epidemiology, Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana. 2. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama; Department of Neurology, Columbia University, New York, New York. 3. Stroke Program, Department of Neurology, Tulane University School of Medicine, New Orleans, Louisiana. 4. Section of Hematology/Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana. 5. Stroke Program, Department of Neurology, Tulane University School of Medicine, New Orleans, Louisiana. Electronic address: smartin2@tulane.edu.
Abstract
BACKGROUND AND PURPOSE: Elevated levels of coagulation factor VIII (FVIII) may persist independent of the acute-phase response; however, this relationship has not been investigated relative to acute ischemic stroke (AIS). We examined the frequency and predictors of persistently elevated FVIII in AIS patients. METHODS: AIS patients admitted between July 2008 and May 2014 with elevated baseline FVIII levels and repeat FVIII levels drawn for more than 7 days postdischarge were included. The patients were dichotomized by repeat FVIII level for univariate analysis at 150% and 200% activity thresholds. An adjusted model was developed to predict the likelihood of persistently elevated FVIII levels. RESULTS: Among 1616 AIS cases, 98 patients with elevated baseline FVIII had repeat FVIII levels. Persistent FVIII elevation was found in more than 75% of patients. At the 150% threshold, the prediction score ranged from 0 to 7 and included black race, female sex, prior stroke, hyperlipidemia, smoking, baseline FVIII > 200%, and baseline von Willebrand factor (vWF) level greater than 200%. At the 200% threshold, the prediction score ranged from 0-5 and included female sex, prior stroke, diabetes mellitus, baseline FVIII level greater 200%, and baseline vWF level greater than 200%. For each 1-point increase in score, the odds of persistent FVIII at both the 150% threshold (odds ratio [OR] = 10.4, 95% confidence interval [CI] 1.63-66.9, P = .0134) and 200% threshold (OR = 10.2, 95% CI 1.82-57.5, P = .0083) increased 10 times. CONCLUSION: Because an elevated FVIII level confers increased stroke risk, our model for anticipating a persistently elevated FVIII level may identify patients at high risk for recurrent stroke. FVIII may be a target for secondary stroke prevention.
BACKGROUND AND PURPOSE: Elevated levels of coagulation factor VIII (FVIII) may persist independent of the acute-phase response; however, this relationship has not been investigated relative to acute ischemic stroke (AIS). We examined the frequency and predictors of persistently elevated FVIII in AIS patients. METHODS: AIS patients admitted between July 2008 and May 2014 with elevated baseline FVIII levels and repeat FVIII levels drawn for more than 7 days postdischarge were included. The patients were dichotomized by repeat FVIII level for univariate analysis at 150% and 200% activity thresholds. An adjusted model was developed to predict the likelihood of persistently elevated FVIII levels. RESULTS: Among 1616 AIS cases, 98 patients with elevated baseline FVIII had repeat FVIII levels. Persistent FVIII elevation was found in more than 75% of patients. At the 150% threshold, the prediction score ranged from 0 to 7 and included black race, female sex, prior stroke, hyperlipidemia, smoking, baseline FVIII > 200%, and baseline von Willebrand factor (vWF) level greater than 200%. At the 200% threshold, the prediction score ranged from 0-5 and included female sex, prior stroke, diabetes mellitus, baseline FVIII level greater 200%, and baseline vWF level greater than 200%. For each 1-point increase in score, the odds of persistent FVIII at both the 150% threshold (odds ratio [OR] = 10.4, 95% confidence interval [CI] 1.63-66.9, P = .0134) and 200% threshold (OR = 10.2, 95% CI 1.82-57.5, P = .0083) increased 10 times. CONCLUSION: Because an elevated FVIII level confers increased stroke risk, our model for anticipating a persistently elevated FVIII level may identify patients at high risk for recurrent stroke. FVIII may be a target for secondary stroke prevention.
Authors: E W Steyerberg; F E Harrell; G J Borsboom; M J Eijkemans; Y Vergouwe; J D Habbema Journal: J Clin Epidemiol Date: 2001-08 Impact factor: 6.437
Authors: James E Siegler; Amelia K Boehme; Adrianne M Dorsey; Dominique J Monlezun; Alex J George; Amir Shaban; H Jeremy Bockholt; Karen C Albright; Sheryl Martin-Schild Journal: Med Student Res J Date: 2013-05-31
Authors: Karin van Dijk; Johanna G van der Bom; Peter J Lenting; Philip G de Groot; Eveline P Mauser-Bunschoten; Goris Roosendaal; Diederick E Grobbee; H Marijke van den Berg Journal: Haematologica Date: 2005-04 Impact factor: 9.941
Authors: Noémi Klára Tóth; Edina Gabriella Székely; Katalin Réka Czuriga-Kovács; Ferenc Sarkady; Orsolya Nagy; Levente István Lánczi; Ervin Berényi; Klára Fekete; István Fekete; László Csiba; Zsuzsa Bagoly Journal: Front Neurol Date: 2018-01-23 Impact factor: 4.003